BMY ▲ +2.0% - Bristol-Myers Squibb Company
$BMY Bristol-Myers Squibb Q3 earnings — EPS $1.35 vs $1.22 est, beat, down 17% YoY — Revenue $13.069B vs $12.73B est, beat, up 7% YoY — EPS down 34% QoQ, revenue up 1% QoQ
29-OCT-2026 07:01 AM ET
Share this post
More filings for $BMY
BMY ▼ -0.6% - Bristol-Myers Squibb CompanyOct 23, 2026BMY ▼ -0.7% - Bristol-Myers Squibb CompanyOct 23, 2026BMY ▲ +4.6% - Bristol-Myers Squibb CompanyOct 12, 2026BMY ▲ +4.6% - Bristol-Myers Squibb CompanyOct 12, 2026BMY ▲ +0.2% - Bristol-Myers Squibb CompanyOct 8, 2026BMY ▼ -2.1% - Bristol-Myers Squibb CompanySep 29, 2026
View full $BMY filing history →💬 Comments
Loading comments…
Leave a comment